Abstract
With acquisition the most likely exit for today’s biotech investors, it pays to keep current with the tastes of pharmaceutical firms when launching a venture
Cite
CITATION STYLE
APA
Giniatullina, A., Boorsma, M., Mulder, G., & Deventer, S. V. (2013). Building a business for big pharma. Nature Publishing Group, 2012, 1–4. https://doi.org/10.1038/bioe.2013.3
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free